Merus N.V. (MRUS): Price and Financial Metrics
MRUS Price/Volume Stats
| Current price | $47.10 | 52-week high | $61.61 |
| Prev. close | $47.64 | 52-week low | $37.77 |
| Day low | $46.65 | Volume | 490,500 |
| Day high | $49.25 | Avg. volume | 647,508 |
| 50-day MA | $43.01 | Dividend yield | N/A |
| 200-day MA | $48.98 | Market Cap | 3.25B |
MRUS Stock Price Chart Interactive Chart >
Merus N.V. (MRUS) Company Bio
Merus B.V., a clinical-stage immuno-oncology company, engages in developing bispecific antibody therapeutics. The company was founded in 2003 and is based in Utrecht, Netherlands.
MRUS Price Returns
| 1-mo | 16.87% |
| 3-mo | 9.97% |
| 6-mo | -6.18% |
| 1-year | 7.29% |
| 3-year | 65.61% |
| 5-year | 283.55% |
| YTD | 12.01% |
| 2024 | 52.91% |
| 2023 | 77.76% |
| 2022 | -51.35% |
| 2021 | 81.40% |
| 2020 | 24.50% |
Continue Researching MRUS
Want to see what other sources are saying about Merus NV's financials and stock price? Try the links below:Merus NV (MRUS) Stock Price | Nasdaq
Merus NV (MRUS) Stock Quote, History and News - Yahoo Finance
Merus NV (MRUS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...